Clinical Trial Update: Silver Nanoparticle Investigation for Treating Chronic Sinusitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating silver nanoparticles for chronic rhinosinusitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Silver nanoparticle formulation (silver nanoparticle)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Chronic Rhinosinusitis (Diagnosis) | Phase 1 | Status: WITHDRAWN